Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
DelMar Pharma
512
DelMar Pharma
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Therapeutics
DelMar Pharma ($DMPI) develops #cancer therapies in new indications where patients have failed or are unlikely to respond to modern therapy. #Glioblastoma
Suggest edits
Founded
2010
Raised
$14.6M
Follow us
Also headquartered in Vancouver
Hootsuite
The Next Big Thing
Lululemon
Sierra Wireless
Trulioo
TELUS
Dapper Labs
Bench
Koho
BuildDirect
Companies in the same industry
PeptiMimesis
IMMT - Institute of Metagenomics...
Trobix Bio
Fulgent Diagnostics
Verona Pharma Plc
ImmunoBiochem Corporation
Lumobiotics
Methylation Sciences
Neos Therapeutics, Inc.
SyntheX
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$9,000,000
Post-IPO equity - 2017
$5,600,000
Post-IPO equity - 2016
Team Size
1–10
Employees
I work here
Location
Vancouver
,
Canada
Headquarters
Explore Vancouver
$9,000,000
Post-IPO equity
Drug Delivery Business
DelMar closes $9m public offering
